Skip to main content
Clinical Trials/NL-OMON34163
NL-OMON34163
Completed
Phase 2

Cochlear*s Direct Acoustic Cochlear Stimulator Investigational Device (C-DACS ID) clinical trial CAG5229 - C-DACS clinical trial CAG5229

Cochlear AG0 sites5 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
fixation of the stapes
Sponsor
Cochlear AG
Enrollment
5
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Cochlear AG

Eligibility Criteria

Inclusion Criteria

  • 1\. Eighteen years of age or older
  • 2\. Mixed severe to profound hearing loss
  • 3\. Conductive hearing loss is a result of otosclerosis or prior failed stapes surgery
  • 4\. Bone conduction thresholds are worse than 40 dB HL on at least 3 out of 5 frequencies (500 Hz, 1 kHz, 2 kHz, 3 kHz and 4 kHz) but must be measurable at all five frequencies
  • 5\. Bone conduction thresholds equal to or greater than 30 dB HL in all frequencies
  • 6\. Air\-bone gap equal to or greater than 30 dB HL on at least 3 out of 5 frequencies
  • 7\. Bone conduction of contra\-lateral ear is equal to or worse than 30 dB HL at the best frequency

Exclusion Criteria

  • 1\. Participation in another medical device study
  • 2\. Unwillingness or inability of the subject to comply with all study requirements
  • 3\. Bone conduction threshold exceeds 80 dB HL at 1 or more out of 5 frequencies (500 Hz, 1 kHz, 2 kHz, 3 kHz and 4 kHz)
  • 4\. Air conduction threshold exceeds 120 dB HL at 1 or more out of 5 frequencies
  • (500 Hz, 1 kHz, 2 kHz, 3 kHz and 4 kHz)
  • 5\. Medical or psychological conditions that would contraindicate undergoing surgery
  • 6\. Sudden hearing loss
  • 7\. Disabling tinnitus
  • 8\. Insufficient mastoid and/or ear canal size (to be checked on CT scan)
  • 9\. Other criteria at investigator\*s discretion

Outcomes

Primary Outcomes

Not specified

Similar Trials